Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

Australia

Flinders Medical Centre, Adelaide

Royal Brisbane and Women's Hospital, Brisbane

Calvary Health Care Bethlehem, Parkdale

Perron Institute, Perth

The University of Sydney (Royal prince Alfred hospital), Sydney

Concord hospital Sydney, Sydney

Belgium

University Hospital Leuven, Leuven

Netherlands

University Medical Center Utrecht, Utrecht, Utrecht

Spain

Bellvitge University Hospital, Barcelona

Sweden

Karolinska University Hospital, Stockholm

United Kingdom

King's College Hospital, London

University College London Hospital NHS, London

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent